| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 37,400 | 39,000 | 07.08. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | COCHLEAR LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| Mi | Earnings preview: can Cochlear shares rebound? | 1 | The Motley Fool Australia | ||
| Mi | COCHLEAR LIMITED: Becoming a substantial holder | - | ASX | ||
| 29.07. | WiseTech, Cochlear, CSL shares: Buy, sell or hold? | 10 | The Motley Fool Australia | ||
| 28.07. | COCHLEAR LIMITED: Notice of FY26 result analyst and media briefing | 3 | ASX | ||
| COCHLEAR LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 27.07. | COCHLEAR LIMITED: Becoming a substantial holder | 5 | ASX | ||
| 24.07. | Cochlear Says Hearing Implants Remain Duty-Free In U.S. After Tariff Decision | 3 | RTTNews | ||
| 24.07. | COCHLEAR LIMITED: Cochlear statement on US tariff announcement | 1 | ASX | ||
| 22.07. | How many Cochlear shares do I need to buy for $10,000 of passive income? | 3 | The Motley Fool Australia | ||
| 18.07. | Here's why I'd buy and hold CSL and Cochlear shares for 10 years | 18 | The Motley Fool Australia | ||
| 16.07. | Health Check: Do we hear more bad news about Cochlear? | 4 | Stockhead | ||
| 15.07. | Cochlear shares have bounced 16%. Should you buy, hold, or sell now? | 7 | The Motley Fool Australia | ||
| 14.07. | Envoy Medical, Inc.: Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant | 480 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - July 14, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| 14.07. | EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results | 2 | Benzinga.com | ||
| 14.07. | COCHLEAR LIMITED: Notification of cessation of securities - COH | - | ASX | ||
| 08.07. | Cochlear shares are slipping again. Is the comeback already over? | 8 | The Motley Fool Australia | ||
| 02.07. | Cochlear shares have jumped 23% in a month: Is there more upside ahead? | 1 | The Motley Fool Australia | ||
| 02.07. | COCHLEAR LIMITED: Change in substantial holding | 2 | ASX | ||
| 30.06. | Health Check: Turn it down on Cochlear expectations, broker warns | 13 | Stockhead | ||
| 25.06. | Buy, hold, sell: Capricorn Metals, Chrysos, Cochlear shares | 11 | The Motley Fool Australia |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,060 | +0,81 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,050 | +0,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,510 | +1,05 % | Börse am Morgen: Hensoldt, Puma, Siemens Healthineers, Börsentermine - Nord/LB | Die Zahl der Arbeitslosen in Deutschland ist im Juli m/m spürbar um 71.000 auf 3,007 Mio. gestiegen, die Arbeitslosenquote kletterte um um 0,2 PP auf 6,4%. Neben saisonalen Effekten wie dem Ausbildungsende... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,900 | +2,05 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,900 | +2,21 % | Eckert & Ziegler: Was die BaFin jetzt untersucht | ||
| INTUITIVE SURGICAL | 327,00 | -0,17 % | Intuitive Surgical: Dieses UBS-Urteil lässt aufhorchen | ||
| MEDTRONIC | 74,52 | -1,17 % | Medtronic Expands CE Mark Indication For Affera System For Ventricular Arrhythmias Treatment | WASHINGTON (dpa-AFX) - Thursday, Medtronic plc (MDT) announced the expansion of the CE Mark indication for the Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular... ► Artikel lesen | |
| TELADOC HEALTH | 6,198 | +0,55 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| STRAUMANN | 110,95 | +0,54 % | Straumann Holding AG: Einladung: Straumann Group - Halbjahresergebnisse 2026 Webcast | Straumann Holding AG
/ Schlagwort(e): Halbjahresergebnis/Quartalsergebnis
Einladung: Straumann Group - Halbjahresergebnisse 2026 Webcast
13.07.2026 / 10:15 CET/CEST
Datum:... ► Artikel lesen | |
| DEXCOM | 72,60 | -1,09 % | Insulet sends Tandem, DexCom lower after guidance cut | ||
| ALIGN TECHNOLOGY | 146,95 | -2,20 % | Align Technology To Add Three Directors And Raise 2026 Share Repurchases To Up To $500 Million | ||
| HENRY SCHEIN | 76,00 | -0,65 % | Henry Schein Inc. Profit Advances In Q2 | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $94 million, or $0.82 per share. This... ► Artikel lesen | |
| TANDEM DIABETES | 18,900 | -2,58 % | Tandem Diabetes Care seeing early benefits of new pay-as-you-go model | ||
| INSULET | 122,50 | +0,37 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| AMBU | 9,820 | 0,00 % | Ambu Q1 2025/26 slides: endoscopy growth offsets FX headwinds |